Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
MLTX similar filings
- 14 Nov 23 MoonLake Immunotherapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update
- 6 Nov 23 MoonLake Immunotherapeutics announces landmark Phase 2 results for Nanobody® sonelokimab in active psoriatic arthritis
- 16 Oct 23 Regulation FD Disclosure
- 11 Sep 23 Regulation FD Disclosure
- 1 Sep 23 Departure of Directors or Certain Officers
- 10 Aug 23 MoonLake Immunotherapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update
- 29 Jun 23 Entry into a Material Definitive Agreement
Filing view
External links
Exhibit 99.1